Astrana Health FY2023 revenue $1.39B (+21%), net income $60.7M (+34%), EPS $1.29 (+30%)

Astrana Health, Inc.

2023-FY EPS reported $1.29 revenue$1,386,661,000

Total revenue $1,386.7M, up 21% from $1,144.2M in 2022.
Net income attributable to Astrana $60.7M, up 34% from $45.2M.
Diluted EPS $1.29, up 30% from $0.99.
Adjusted EBITDA $146.6M, up 5% from $140.0M.
Care Partners revenue $1,300.1M, up 24% from $1,051.5M.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Astrana Health, Inc. reported three and twelve months ended December 31, 2023 results: revenue $1,386.7 million, net income $60.7 million, EPS $1.29.

Period: three and twelve months ended December 31, 2023
Revenue: $1,386.7 million
Net income: $60.7 million
EPS: $1.29
Result: reported results

Exact text from the filing

of Astrana Health. Financial Highlights for the Year Ended December 31, 2023: All comparisons are to year ended December 31, 2022 unless otherwise stated. • Total revenue of $1,386.7 million, up 21% from $1,144.2 million • Care Partners revenue of $1,300.1 million, up 24% from $1,051.5 million • Net income attributable to Astrana of $60.7 million, up 34% from

View on SEC.gov

51 earnings releases filed in the last 30 days. Browse all earnings releases →

Astrana Health, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-24-028213

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.